[ccpw id="5"]

Home.forex news reportJim Cramer Says He “Wouldn’t Mind a Speculative Position Only on Roblox”

Jim Cramer Says He “Wouldn’t Mind a Speculative Position Only on Roblox”

-


Roblox Corporation (NYSE:RBLX) is one of the stocks Jim Cramer talked about. Mentioning that they are considering it as a speculative play, a caller asked if the stock is a buy, given that it is down around 50% from its highs last year. Cramer replied:

“Okay, now, this company is a very, very good company that people decided to pay too much for. In other words, because it’s losing money, this market no longer wants it. Remember what I said, last year was the year of magical investing. That year’s over. If you’re losing money, people don’t want to touch it. That said, Dave Baszucki does a good job running it. I wouldn’t mind a speculative position only on Roblox.”

 

Roblox_oberon-copeland-veryinformed-com-TWcT7gG59js-unsplash

Roblox Corporation (NYSE:RBLX) runs an online platform where users can play, create, and share interactive 3D experiences. Brown Advisory stated the following regarding Roblox Corporation (NYSE:RBLX) in its third quarter 2025 investor letter:

“Roblox Corporation’s (NYSE:RBLX) two-sided gaming platform continues to gain share, with stronger engagement and operating leverage driven by improved search algorithms and recent hit titles. Third-party data suggests bookings are accelerating despite tougher comparisons.”

While we acknowledge the potential of RBLX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

LATEST POSTS

Amylyx Pharmaceuticals (AMLX) Announces the Selection of AMX0318 as Development Candidate for PBH and Other Rare Diseases

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) is one of the best performing pharma stocks in 2025. Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) announced on January...

Indivior PLC (INDV) Announces Full-Year 2026 Financial Guidance

Indivior PLC (NASDAQ:INDV) is one of the best performing pharma stocks in 2025. Indivior PLC (NASDAQ:INDV) announced its full-year 2026 financial...

FX Watch: USD/JPY and AUD/USD’s Setups if U.S. CPI Encourages Aggressive Fed Rate Cuts

Will U.S. dollar bears make a comeback as Uncle Sam rolls out its latest inflation updates? Our Event Guide for the U.S. CPI report points...

Truist Raises PT on Amneal Pharmaceuticals (AMRX) to $15 From $14

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) is one of the best performing pharma stocks in 2025. On January 7, Truist raised the price...

Follow us

0FansLike
0FollowersFollow
0SubscribersSubscribe

Most Popular

spot_img